These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10710505

  • 1. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations.
    Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM.
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E501-8. PubMed ID: 10710505
    [Abstract] [Full Text] [Related]

  • 2. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
    Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1834-8. PubMed ID: 9177392
    [Abstract] [Full Text] [Related]

  • 3. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T, Abbasi F, Lamendola C, Kim HS, Reaven GM.
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [Abstract] [Full Text] [Related]

  • 4. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [Abstract] [Full Text] [Related]

  • 5. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?
    Carantoni M, Abbasi F, Azhar S, Schaaf P, Reaven GM.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):869-72. PubMed ID: 10084563
    [Abstract] [Full Text] [Related]

  • 6. Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
    Kim SH, Abbasi F, Chu JW, McLaughlin TL, Lamendola C, Polonsky KS, Reaven GM.
    Diabetes; 2005 Aug; 54(8):2447-52. PubMed ID: 16046313
    [Abstract] [Full Text] [Related]

  • 7. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women.
    Bützow TL, Lehtovirta M, Siegberg R, Hovatta O, Koistinen R, Seppäla M, Apter D.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3271-5. PubMed ID: 10999821
    [Abstract] [Full Text] [Related]

  • 8. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
    Carpentier A, Giacca A, Lewis GF.
    Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
    [Abstract] [Full Text] [Related]

  • 9. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
    Polonsky KS, Given BD, Van Cauter E.
    J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730
    [Abstract] [Full Text] [Related]

  • 10. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G.
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [Abstract] [Full Text] [Related]

  • 11. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
    Van Cauter E, Mestrez F, Sturis J, Polonsky KS.
    Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497
    [Abstract] [Full Text] [Related]

  • 12. Weight loss-associated changes in acute effects of nateglinide on insulin secretion after glucose loading: results of glucose loading on 2 consecutive days.
    Mori Y, Mamori S, Tajima N.
    Diabetes Obes Metab; 2005 Mar; 7(2):182-8. PubMed ID: 15715891
    [Abstract] [Full Text] [Related]

  • 13. Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance.
    Reaven GM, Moore J, Greenfield M.
    Diabetes; 1983 Jul; 32(7):600-4. PubMed ID: 6345239
    [Abstract] [Full Text] [Related]

  • 14. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [Abstract] [Full Text] [Related]

  • 15. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain.
    Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V.
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E568-75. PubMed ID: 18171910
    [Abstract] [Full Text] [Related]

  • 16. Effects of muscarinic blockade on insulin secretion and on glucose-induced thermogenesis in lean and obese human subjects.
    Schneeberger D, Tappy L, Temler E, Jequier E.
    Eur J Clin Invest; 1991 Dec; 21(6):608-15. PubMed ID: 1778222
    [Abstract] [Full Text] [Related]

  • 17. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G, Lucisano A, Liberale I, Barini A, Vuolo IP, Martino G, Menini E, Dell'Acqua S.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [Abstract] [Full Text] [Related]

  • 18. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [Abstract] [Full Text] [Related]

  • 19. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
    Bonora E, Zavaroni I, Bruschi F, Alpi O, Pezzarossa A, Guerra L, Dall'Aglio E, Coscelli C, Butturini U.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
    [Abstract] [Full Text] [Related]

  • 20. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
    Ehrmann DA, Breda E, Cavaghan MK, Bajramovic S, Imperial J, Toffolo G, Cobelli C, Polonsky KS.
    Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.